Avenzo collects another $60M for two small molecules and two ADCs licensed from China September 22, 2025
Solu Developing a Powerful New Therapeutic Modality that Unlocks Cell Surface Targets September 12, 2025
Newleos Therapeutics Expands Leadership Team to Advance its Clinical-Stage Neuropsychiatric Programs and Drive Corporate Growth April 8, 2025
